Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/atorvastatin versus atorvastatin alone in adults with heterozygous familial hypercholesterolemia
2004-004269-14Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in familial hypercholesterolemia (FH) comparing Torcetrapib + atorvastatin with Atorvastatin alone (2 arms). Primary endpoints: Percent change in LDL-C from baseline and Percent change in HDL-C from baseline. Started Jan 2005; status: completed.
02
Drugs
rocacetrapibatorvastatin
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2004-004269-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004269-14.